Brokerages Set Healthpeak Properties, Inc. (NYSE:DOC) Price Target at $19.86

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have received a consensus rating of “Hold” from the seventeen brokerages that are currently covering the firm, MarketBeat reports. Fourteen analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $19.9333.

DOC has been the topic of a number of recent analyst reports. UBS Group increased their price target on Healthpeak Properties from $17.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Raymond James Financial assumed coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating for the company. Citigroup raised their price target on Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Finally, JPMorgan Chase & Co. lifted their price target on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday.

Insider Transactions at Healthpeak Properties

In related news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.23% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in Healthpeak Properties during the fourth quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Healthpeak Properties by 60.3% in the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after buying an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after buying an additional 4,776,056 shares during the period. Finally, Bank of America Corp DE grew its position in shares of Healthpeak Properties by 27.5% during the 1st quarter. Bank of America Corp DE now owns 11,887,795 shares of the real estate investment trust’s stock valued at $195,316,000 after buying an additional 2,563,407 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $21.51 on Monday. The firm’s fifty day simple moving average is $19.06 and its 200-day simple moving average is $17.66. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market cap of $14.83 billion, a PE ratio of 67.22, a price-to-earnings-growth ratio of 3.31 and a beta of 1.05. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $21.56.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to analysts’ expectations of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts expect that Healthpeak Properties will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 15th were paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 5.7%. The ex-dividend date was Monday, June 15th. Healthpeak Properties’s payout ratio is currently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.